These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38135096)

  • 1. Cannabinoid CB2 receptors and hypersensitivity to methamphetamine: Vulnerability to schizophrenia.
    Canseco-Alba A; Tabata K; Momoki Y; Tabassum T; Horiuchi Y; Arinami T; Onaivi ES; Ishiguro H
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110924. PubMed ID: 38135096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.
    Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.
    Canseco-Alba A; Schanz N; Sanabria B; Zhao J; Lin Z; Liu QR; Onaivi ES
    Behav Brain Res; 2019 Mar; 360():286-297. PubMed ID: 30508607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice.
    Shapiro L; Wong JC; Escayg A
    Epilepsia; 2019 Dec; 60(12):2359-2369. PubMed ID: 31758544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder.
    Canseco-Alba A; Sanabria B; Hammouda M; Bernadin R; Mina M; Liu QR; Onaivi ES
    Front Psychiatry; 2021; 12():803394. PubMed ID: 35211038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid CB2 Receptor Gene and Environmental Interaction in the Development of Psychiatric Disorders.
    Ishiguro H; Horiuchi Y; Tabata K; Liu QR; Arinami T; Onaivi ES
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30042304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference.
    Liu QR; Canseco-Alba A; Zhang HY; Tagliaferro P; Chung M; Dennis E; Sanabria B; Schanz N; Escosteguy-Neto JC; Ishiguro H; Lin Z; Sgro S; Leonard CM; Santos-Junior JG; Gardner EL; Egan JM; Lee JW; Xi ZX; Onaivi ES
    Sci Rep; 2017 Dec; 7(1):17410. PubMed ID: 29234141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies.
    García-Gutiérrez MS; Navarrete F; Gasparyan A; Navarro D; Morcuende Á; Femenía T; Manzanares J
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors.
    Powers MS; Breit KR; Chester JA
    Alcohol Clin Exp Res; 2015 Dec; 39(12):2438-46. PubMed ID: 26756798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids affect the mouse visual acuity via the cannabinoid receptor type 2.
    Cécyre B; Bachand I; Papineau F; Brochu C; Casanova C; Bouchard JF
    Sci Rep; 2020 Sep; 10(1):15819. PubMed ID: 32978469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CB
    Zhang HY; Shen H; Jordan CJ; Liu QR; Gardner EL; Bonci A; Xi ZX
    Acta Pharmacol Sin; 2019 Mar; 40(3):398-409. PubMed ID: 29967455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain cannabinoid CB2 receptor in schizophrenia.
    Ishiguro H; Horiuchi Y; Ishikawa M; Koga M; Imai K; Suzuki Y; Morikawa M; Inada T; Watanabe Y; Takahashi M; Someya T; Ujike H; Iwata N; Ozaki N; Onaivi ES; Kunugi H; Sasaki T; Itokawa M; Arai M; Niizato K; Iritani S; Naka I; Ohashi J; Kakita A; Takahashi H; Nawa H; Arinami T
    Biol Psychiatry; 2010 May; 67(10):974-82. PubMed ID: 19931854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy.
    Szczesniak AM; Porter RF; Toguri JT; Borowska-Fielding J; Gebremeskel S; Siwakoti A; Johnston B; Lehmann C; Kelly ME
    Neuropharmacology; 2017 Feb; 113(Pt B):627-638. PubMed ID: 27569993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.
    Agudo J; Martin M; Roca C; Molas M; Bura AS; Zimmer A; Bosch F; Maldonado R
    Diabetologia; 2010 Dec; 53(12):2629-40. PubMed ID: 20835701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid CB2 receptors modulate alcohol induced behavior, and neuro-immune dysregulation in mice.
    Kibret BG; Roberts A; Kneebone A; Embaby S; Fernandez J; Liu QR; Onaivi ES
    Behav Brain Res; 2023 Jun; 448():114439. PubMed ID: 37061199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice.
    Zhang HY; Gao M; Liu QR; Bi GH; Li X; Yang HJ; Gardner EL; Wu J; Xi ZX
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E5007-15. PubMed ID: 25368177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological regulation of cannabinoid CB2 receptor modulates the reinforcing and motivational actions of ethanol.
    Navarrete F; García-Gutiérrez MS; Manzanares J
    Biochem Pharmacol; 2018 Nov; 157():227-234. PubMed ID: 30063884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adolescent neuregulin 1 heterozygous mice display enhanced behavioural sensitivity to methamphetamine.
    Spencer JR; Darbyshire KM; Boucher AA; Arnold JC
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):376-81. PubMed ID: 22850204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of cannabinoid CB
    Ma Z; Gao F; Larsen B; Gao M; Luo Z; Chen D; Ma X; Qiu S; Zhou Y; Xie J; Xi ZX; Wu J
    EBioMedicine; 2019 Apr; 42():225-237. PubMed ID: 30952618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents.
    Bi GH; Galaj E; He Y; Xi ZX
    Addict Biol; 2020 Jul; 25(4):e12783. PubMed ID: 31215752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.